Comparison between Rajgor Castor Derivatives IPO and Saakshi Medtech IPO.
Rajgor Castor Derivatives IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Saakshi Medtech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Rajgor Castor Derivatives IPO | Saakshi Medtech IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Rajgor Castor Derivatives IPO is up to ₹45.30 Cr whereas the issue size of the Saakshi Medtech IPO is up to ₹42.88 Cr. The final issue price of Rajgor Castor Derivatives IPO is ₹50.00 per share and of Saakshi Medtech IPO is ₹97.00 per share.
| Rajgor Castor Derivatives IPO | Saakshi Medtech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹47.00 per share | ₹92.00 per share |
| Issue Price (Upper) | ₹50.00 per share | ₹97.00 per share |
| Issue Price (Final) | ₹50.00 per share | ₹97.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1200 shares |
| Fresh Issue Size | 83,94,000 shares | 44,20,800 shares |
| Fresh Issue Size (Amount) | up to ₹41.97 Cr | up to ₹42.88 Cr |
| OFS Issue Size | 6,66,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹3.33 Cr | up to ₹0.00 Cr |
| Issue Size Total | 90,60,000 shares | 44,20,800 shares |
| Issue Size Total (Amount) | up to ₹45.30 Cr | up to ₹42.88 Cr |
Rajgor Castor Derivatives IPO opens on Oct 17, 2023, while Saakshi Medtech IPO opens on Sep 25, 2023. The closing date of Rajgor Castor Derivatives IPO and Saakshi Medtech IPO is Oct 20, 2023, and Sep 27, 2023, respectively.
| Rajgor Castor Derivatives IPO | Saakshi Medtech IPO | |
|---|---|---|
| Anchor Bid Date | Oct 16, 2023 | Sep 22, 2023 |
| Issue Open | Oct 17, 2023 | Sep 25, 2023 |
| Issue Close | Oct 20, 2023 | Sep 27, 2023 |
| Basis Of Allotment (Tentative) | Oct 26, 2023 | Oct 03, 2023 |
| Initiation of Refunds (Tentative) | Oct 27, 2023 | Oct 04, 2023 |
| Credit of Share (Tentative) | Oct 30, 2023 | Oct 05, 2023 |
| Listing date (Tentative) | Oct 31, 2023 | Oct 03, 2023 |
| Anchor Lockin End date 1 | Nov 25, 2023 | Nov 02, 2023 |
| Anchor Lockin End date 2 | Jan 24, 2024 | Jan 01, 2024 |
Rajgor Castor Derivatives IPO P/E ratio is 1.66, as compared to Saakshi Medtech IPO P/E ratio of 10.18.
| Rajgor Castor Derivatives IPO | Saakshi Medtech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 1.66 | 10.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹119.58 Cr. | ₹171.26 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 43.19% | 34.35% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 22.97% | 28.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.88 | 0.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹30.06 | ₹9.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.44% | 29.32% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Rajgor Castor Derivatives IPO Retail Individual Investors (RII) are offered 31,74,000 shares while in Saakshi Medtech IPO retail investors are offered 31,74,000 shares. Qualified Institutional Buyers (QIB) are offered 18,12,000 shares in Rajgor Castor Derivatives IPO and 8,84,400 shares in Saakshi Medtech IPO.
| Rajgor Castor Derivatives IPO | Saakshi Medtech IPO | |
|---|---|---|
| Anchor Investor Reservation | 27,12,000 shares | 13,24,800 shares |
| Market Maker Reservation | 5,01,000 shares | 2,35,200 shares |
| QIB | 18,12,000 shares | 8,84,400 shares |
| NII | 13,62,000 shares | 6,63,600 shares |
| RII | 31,74,000 shares | 15,48,000 shares |
| Employee | ||
| Others | ||
| Total | 90,60,000 shares | 44,20,800 shares |
Rajgor Castor Derivatives IPO subscribed 107.43x in total, whereas Saakshi Medtech IPO subscribed 91.65x.
| Rajgor Castor Derivatives IPO | Saakshi Medtech IPO | |
|---|---|---|
| QIB (times) | 35.52x | 37.35x |
| NII (times) | 260.01x | 200.78x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 80.70x | 75.88x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 107.43x | 91.65x |
